Interpace Diagnostics Group Company Profile (NASDAQ:IDXG)

About Interpace Diagnostics Group (NASDAQ:IDXG)

Interpace Diagnostics Group logoInterpace Diagnostics Group, Inc., formerly PDI, Inc., is focused on developing and commercializing molecular diagnostic tests principally focused on early detection of high potential progressors to cancer and leveraging the latest technology and personalized medicine for patient diagnosis and management. The Company operates through molecular diagnostics segment. It offers molecular tests, such as PancraGen, which is a pancreatic cyst molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment utilizing its PathFinder platform; ThyGenX, which assesses thyroid nodules for risk of malignancy, and ThyraMIR, which assesses thyroid nodules risk of malignancy utilizing a gene expression assay. Through its molecular diagnostics business, the Company provides diagnostic options for detecting genetic and other molecular alterations that are associated with gastrointestinal and endocrine cancers, which are focused on early detection of cancer.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Business Support Services - NEC
  • Sub-Industry: Health Care Services
  • Symbol: NASDAQ:IDXG
  • CUSIP: 69329V10
  • Web: www.interpacediagnostics.com
Capitalization:
  • Market Cap: $16.33 million
  • Outstanding Shares: 8,788,000
Average Prices:
  • 50 Day Moving Avg: $1.19
  • 200 Day Moving Avg: $2.60
  • 52 Week Range: $0.70 - $19.80
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.000
Sales & Book Value:
  • Annual Revenue: $13.52 million
  • Price / Sales: 0.56
  • Book Value: $3.65 per share
  • Price / Book: 0.24
Profitability:
  • EBIDTA: ($10,020,000.00)
  • Net Margins: -8.45%
  • Return on Equity: -28.77%
  • Return on Assets: -5.44%
Debt:
  • Debt-to-Equity Ratio: 0.18%
  • Current Ratio: 0.82%
  • Quick Ratio: 0.82%
Misc:
  • Average Volume: 1.56 million shs.
  • Beta: 1.8
  • Short Ratio: 0.7
 

Frequently Asked Questions for Interpace Diagnostics Group (NASDAQ:IDXG)

What is Interpace Diagnostics Group's stock symbol?

Interpace Diagnostics Group trades on the NASDAQ under the ticker symbol "IDXG."

How were Interpace Diagnostics Group's earnings last quarter?

Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) issued its quarterly earnings results on Monday, May, 15th. The company reported $0.42 EPS for the quarter. The firm had revenue of $3.47 million for the quarter. Interpace Diagnostics Group had a negative net margin of 8.45% and a negative return on equity of 28.77%. View Interpace Diagnostics Group's Earnings History.

Who are some of Interpace Diagnostics Group's key competitors?

Who are Interpace Diagnostics Group's key executives?

Interpace Diagnostics Group's management team includes the folowing people:

  • Stephen J. Sullivan, Chairman of the Board
  • Jack E. Stover CPA, President, Chief Executive Officer, Director
  • James Early, Chief Financial Officer, Principal Financial Officer, Principal Accounting Officer
  • Joseph D. Keegan Ph.D., Independent Director

How do I buy Interpace Diagnostics Group stock?

Shares of Interpace Diagnostics Group can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Interpace Diagnostics Group's stock price today?

One share of Interpace Diagnostics Group stock can currently be purchased for approximately $0.87.


MarketBeat Community Rating for Interpace Diagnostics Group (NASDAQ IDXG)
Community Ranking:  2.4 out of 5 ( )
Outperform Votes:  26 (Vote Outperform)
Underperform Votes:  29 (Vote Underperform)
Total Votes:  55
MarketBeat's community ratings are surveys of what our community members think about Interpace Diagnostics Group and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Interpace Diagnostics Group (NASDAQ:IDXG) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Interpace Diagnostics Group (NASDAQ:IDXG)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/21/2015William BlairReiterated RatingMarket PerformN/AView Rating Details
8/25/2015Roth CapitalReiterated RatingBuyN/AView Rating Details
(Data available from 7/20/2015 forward)

Earnings

Earnings History for Interpace Diagnostics Group (NASDAQ:IDXG)
Earnings by Quarter for Interpace Diagnostics Group (NASDAQ:IDXG)
Earnings History by Quarter for Interpace Diagnostics Group (NASDAQ IDXG)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/15/2017Q1 2017$0.42$3.47 millionViewN/AView Earnings Details
11/12/2015Q3($0.40)($0.31)$32.35 million$36.60 millionViewListenView Earnings Details
8/13/2015Q215($0.46)($0.44)$32.62 million$34.10 millionViewListenView Earnings Details
5/12/2015Q115($0.48)($0.25)$33.20 million$38.30 millionViewListenView Earnings Details
3/3/2015Q414($0.50)($0.27)$140.87 million$28.90 millionViewListenView Earnings Details
11/3/2014Q3($0.19)($0.29)$33.40 million$29.20 millionViewListenView Earnings Details
8/13/2014Q2($0.12)($0.17)$35.60 million$31.60 millionViewListenView Earnings Details
5/7/2014Q1($0.11)($0.11)$39.48 million$32.80 millionViewListenView Earnings Details
2/27/2014Q4($0.11)($0.25)$38.09 million$36.41 millionViewListenView Earnings Details
11/12/2013Q3($0.23)($0.14)ViewListenView Earnings Details
8/5/2013Q2 2013($0.11)($0.06)$35.26 million$37.20 millionViewListenView Earnings Details
3/6/2013Q4 2012($0.07)($1.64)$36.90 million$35.60 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Interpace Diagnostics Group (NASDAQ:IDXG)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Interpace Diagnostics Group (NASDAQ:IDXG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Interpace Diagnostics Group (NASDAQ:IDXG)
Insider Ownership Percentage: 2.50%
Institutional Ownership Percentage: 1.44%
Insider Trades by Quarter for Interpace Diagnostics Group (NASDAQ:IDXG)
Insider Trades by Quarter for Interpace Diagnostics Group (NASDAQ:IDXG)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/25/2014Graham G MiaoCFOBuy22,000$1.65$36,300.00View SEC Filing  
11/10/2014Nancy LurkerCEOBuy49,000$1.75$85,750.00View SEC Filing  
11/7/2014Gerald R Melillo JrInsiderBuy5,000$1.58$7,900.00View SEC Filing  
11/7/2014Jeffrey Edward SmithVPBuy200,000$1.75$350,000.00View SEC Filing  
11/6/2014Nancy LurkerCEOBuy57,000$1.74$99,180.00View SEC Filing  
11/5/2014Gerald P BelleDirectorBuy57,300$1.71$97,983.00View SEC Filing  
11/18/2013Gerald BelleDirectorBuy20,400$5.21$106,284.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Interpace Diagnostics Group (NASDAQ:IDXG)
Latest Headlines for Interpace Diagnostics Group (NASDAQ:IDXG)
Source:
DateHeadline
americanbankingnews.com logoInterpace Diagnostics Group (NASDAQ:IDXG) and Cintas Corporation (CTAS) Head to Head Survey
www.americanbankingnews.com - July 16 at 8:14 PM
streetinsider.com logoInterpace Diagnostics (IDXG) Enters National Contract with Aetna for ThyGenX and ThyraMIR Tests
www.streetinsider.com - June 28 at 7:21 PM
finance.yahoo.com logoInterpace Diagnostics Announces National Contract with Aetna
finance.yahoo.com - June 28 at 7:21 PM
streetinsider.com logoInterpace Diagnostics (IDXG) Says Premera Blue Cross Agrees to Coverage of Thyroid Test
www.streetinsider.com - June 26 at 7:38 PM
finance.yahoo.com logoInterpace Diagnostics Announces Coverage of Thyroid Test By Premera Blue Cross
finance.yahoo.com - June 26 at 7:38 PM
finance.yahoo.com logoInterpace Diagnostics Announces Closing of $13.7 Million Public Offering
finance.yahoo.com - June 21 at 3:31 PM
reuters.com logoBRIEF-Interpace Diagnostics announces pricing
www.reuters.com - June 17 at 6:20 PM
streetinsider.com logoInterpace Diagnostics (IDXG) Prices 12.5M Share Common Offering at $1.10/Sh
www.streetinsider.com - June 17 at 6:20 PM
finance.yahoo.com logoInterpace Diagnostics Announces Pricing of $13.7 Million Underwritten Public Offering of Common Stock and Common Warrants
finance.yahoo.com - June 16 at 6:42 PM
globenewswire.com logoInterpace Diagnostics Announces Agreement with Einstein Medical Center of Philadelphia
globenewswire.com - June 5 at 10:02 AM
finance.yahoo.com logoInterpace Diagnostics Announces Launch of Enhancement to Thyroid Testing Services
finance.yahoo.com - May 24 at 5:41 PM
finance.yahoo.com logoInterpace Diagnostics Group, Inc. :IDXG-US: Earnings Analysis: Q1, 2017 By the Numbers : May 24, 2017
finance.yahoo.com - May 24 at 11:37 AM
americanbankingnews.com logoInterpace Diagnostics Group Inc (IDXG) Releases Quarterly Earnings Results
www.americanbankingnews.com - May 16 at 4:44 PM
finance.yahoo.com logoEdited Transcript of IDXG earnings conference call or presentation 15-May-17 8:30pm GMT
finance.yahoo.com - May 16 at 11:12 AM
reuters.com logoBRIEF-Interpace Diagnostics qtrly EPS from continuing operations $0.42
www.reuters.com - May 15 at 10:57 AM
finance.yahoo.com logoInterpace Diagnostics Group Reports First Quarter 2017 Financial Results, Business Progress and Recent Accomplishments
finance.yahoo.com - May 15 at 10:57 AM
finance.yahoo.com logoInterpace Diagnostics to Host Conference Call and Webcast to Discuss First Quarter 2017 Financial Results on Monday May 15, 2017
finance.yahoo.com - May 12 at 6:31 PM
finance.yahoo.com logoInterpace Diagnostics Presents New Data on PancraGEN® at DDW
finance.yahoo.com - May 10 at 1:25 PM
streetinsider.com logoInterpace Diagnostics (IDXG) to Present New Data in Six Posters Related to PancraGEN at DDW Meeting
www.streetinsider.com - May 1 at 1:22 PM
finance.yahoo.com logoInterpace Diagnostics to Present New Data in Six Posters Related to PancraGEN™ at Upcoming Annual DDW International Meeting on May 6-9, 2017
finance.yahoo.com - May 1 at 1:22 PM
finance.yahoo.com logoInterpace Diagnostics to Present at RedChip's Global Online Growth Conference
finance.yahoo.com - April 24 at 8:48 AM
finance.yahoo.com logoInterpace Diagnostics Eliminates Long Term Secured Debt
finance.yahoo.com - April 20 at 11:33 AM
streetinsider.com logoInterpace Diagnostics (IDXG) Reports Coverage of ThyraMIR with UnitedHealthcare
www.streetinsider.com - April 19 at 10:43 PM
nasdaq.com logoMid-Afternoon Market Update: GNC Gains On Upbeat Earnings; Barracuda Shares Drop
www.nasdaq.com - April 18 at 5:22 PM
finance.yahoo.com logoInterpace Announces Coverage of ThyraMIR® with UnitedHealthcare
finance.yahoo.com - April 18 at 11:06 AM
americanbankingnews.com logoInterpace Diagnostics Group Inc (IDXG) Short Interest Up 24.8% in March
www.americanbankingnews.com - April 13 at 4:50 PM
finance.yahoo.com logoInterpace Diagnostics Announces Receipt of Letter From Nasdaq Confirming Compliance With Minimum Stockholders' Equity Requirement
finance.yahoo.com - April 13 at 10:18 AM
finance.yahoo.com logoInterpace Diagnostics Group, Inc. :IDXG-US: Earnings Analysis: Q4, 2016 By the Numbers : April 11, 2017
finance.yahoo.com - April 11 at 11:57 AM
finance.yahoo.com logoA Look at Interpace Diagnostics Financials, Drug Pipeline and Market Opportunity
finance.yahoo.com - April 7 at 10:23 AM
reuters.com logoBRIEF-Interpace Diagnostics enters into waiver agreement of company's senior secured convertible note
www.reuters.com - April 4 at 2:58 AM
finance.yahoo.com logoInterpace Diagnostics Announces European Patent Approval For Underlying Technology of its ThyraMIR® microRNA Classifier
finance.yahoo.com - April 4 at 2:58 AM
investopedia.com logoInterpace Diagnostics Gets EU Patent for Thyroid Test
www.investopedia.com - April 3 at 4:03 PM
finance.yahoo.com logoInterpace Diagnostics Group Inc. to Present at The MicroCap Conference on April 4th at 9 AM in New York City at the Essex House
finance.yahoo.com - March 31 at 5:51 PM
biz.yahoo.com logoINTERPACE DIAGNOSTICS GROUP, INC. Files SEC form 10-K, Annual Report
biz.yahoo.com - March 31 at 5:51 PM
nasdaq.com logoBUZZ-U.S. STOCKS ON THE MOVE-ConocoPhillips, Lululemon, BiondVax Pharma, Interpace Diagnostics - Nasdaq
www.nasdaq.com - March 30 at 11:16 PM
feeds.benzinga.com logo20 Stocks Moving In Thursday's Pre-Market Session
feeds.benzinga.com - March 30 at 9:10 AM
finance.yahoo.com logoEdited Transcript of IDXG earnings conference call or presentation 29-Mar-17 8:30pm GMT
finance.yahoo.com - March 30 at 8:11 AM
finance.yahoo.com logoInterpace Diagnostics Group Reports Fourth Quarter and Full Year 2016 Financial Results, Business Progress Against Plan and Recent Accomplishments
finance.yahoo.com - March 29 at 6:23 PM
biz.yahoo.com logoINTERPACE DIAGNOSTICS GROUP, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statem
biz.yahoo.com - March 29 at 6:23 PM
finance.yahoo.com logoInterpace Diagnostics Group Announces Timing of Earnings Release and Investor Conference Call
finance.yahoo.com - March 28 at 5:28 PM
americanbankingnews.com logoInterpace Diagnostics Group Inc (IDXG) Set to Announce Earnings on Tuesday
www.americanbankingnews.com - March 27 at 7:11 AM
seekingalpha.com logoInterpace Diagnostics restructures debt in convertible stock and warrant deal; shares ease 6% premarket
seekingalpha.com - March 23 at 6:24 PM
us.rd.yahoo.com logoInterpace Diagnostics Group Announces Agreements to Successfully Restructure Debt and Terminate Royalty and Milestone Obligations
us.rd.yahoo.com - March 23 at 6:24 PM
rttnews.com logoInterpace Diagnostics Group (IDXG) Is Surging In Early Trade
www.rttnews.com - March 22 at 9:59 AM
finance.yahoo.com logoInterpace Diagnostics Participates in USA Today Endocrine Health Campaign
finance.yahoo.com - March 20 at 6:56 PM
americanbankingnews.com logoShort Interest in Interpace Diagnostics Group Inc (IDXG) Expands By 25.5%
www.americanbankingnews.com - March 13 at 10:06 AM
americanbankingnews.com logoSecure Property Development & Invest PLC (SPDI) Insider Harin Thaker Purchases 11,250 Shares
www.americanbankingnews.com - March 9 at 4:45 AM
finance.yahoo.com logoInterpace Diagnostics to Present New Data on Thyroid Product Performance
finance.yahoo.com - February 27 at 6:46 PM
streetinsider.com logoInterpace Diagnostics (IDXG) Enters into Pact with Viatar CTC Solutions - StreetInsider.com
www.streetinsider.com - February 22 at 6:01 PM
us.rd.yahoo.com logo8:01 am Interpace Diagnostics announces the initiation of a collaborative research program with Viatar CTC Solutions to detect and characterize early cancer in liquid biopsies; financial details not disclosed
us.rd.yahoo.com - February 22 at 12:42 PM

Social

Chart

Interpace Diagnostics Group (IDXG) Chart for Thursday, July, 20, 2017

This page was last updated on 7/20/2017 by MarketBeat.com Staff